Inflammatory Bowel Disease (IBD) patients frequently report adverse drug reactions during biologic therapy: A multicentre, prospective, patient-reported pharmacovigilance monitoring system

被引：0
|
作者：
Thomas, P. [1 ]
West, R. [2 ]
Russel, M. [3 ]
Jansen, J. [4 ]
Van Lint, J. [5 ]
Jessurun, N. [5 ]
Romkens, T. [6 ]
Hoentjen, F. [1 ]
机构：
[1] Radboud Univ Nijmegen, Gastroenterol, Med Ctr, Nijmegen, Netherlands
[2] Franciscus Gasthuis & Vlietland, Gastroenterol, Rotterdam, Netherlands
[3] Med Spectrum Twente, Gastroenterol, Enschede, Netherlands
[4] Onze Lieve Vrouw Gasthuis, Gastroenterol, Amsterdam, Netherlands
[5] Pharmacovigilance Ctr LAREB, Pharmacovigilancy, Shertogenbosch, Netherlands
[6] Jeroen Bosch Ziekenhuis, Gastroenterol, Shertogenbosch, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P330
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 47 条
  • [41] Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
    Chanchlani, Neil
    Lin, Simeng
    Auth, Marcus K.
    Lee, Chai Leng
    Robbins, Helena
    Looi, Shi
    Murugesan, Senthil, V
    Riley, Tom
    Preston, Cathryn
    Stephenson, Sophie
    Cardozo, Wendy
    Sonwalkar, Sunil A.
    Allah-Ditta, Mohammed
    Mansfield, Lynne
    Durai, Dharmaraj
    Baker, Mark
    London, Ian
    London, Emily
    Gupta, Sanjay
    Di Mambro, Alex
    Murphy, Aisling
    Gaynor, Edward
    Jones, Kelsey D. J.
    Claridge, Andrew
    Sebastian, Shaji
    Ramachandran, Sankaranarayanan
    Selinger, Christian P.
    Borg-Bartolo, Simon P.
    Knight, Paul
    Sprakes, Michael B.
    Burton, Julie
    Kane, Patricia
    Lupton, Stephanie
    Fletcher, Aimee
    Gaya, Daniel R.
    Colbert, Roghan
    Seenan, John Paul
    MacDonald, Jonathan
    Lynch, Lucy
    McLachlan, Iain
    Shields, Stephanie
    Hansen, Richard
    Gervais, Lisa
    Jere, Mwansa
    Akhtar, Muhammad
    Black, Karen
    Henderson, Paul
    Russell, Richard K.
    Lees, Charlie W.
    Derikx, Lauranne A. A. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1250 - 1263
  • [42] Risk of Solid Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System
    Stobaugh, Derrick J.
    Deepak, Parakkal
    Ehrenpreis, Eli D.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S416 - S416
  • [43] Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease
    Sands, Bruce E.
    Panes, Julian
    Feagan, Brian G.
    Zhang, Hongyan
    Vetter, Marion L.
    Mathias, Susan D.
    Huang, Kuan-Hsiang Gary
    Johanns, Jewel
    Germinaro, Matthew
    Sahoo, Aparna
    Terry, Natalie A.
    Han, Chenglong
    [J]. VALUE IN HEALTH, 2024, 27 (09) : 1 - 10
  • [44] Analysis of the Food and Drug Administration Adverse Event Reporting System to Examine the Relationship between Tumor Necrosis Factor Alpha Inhibitor Therapy and Congestive Heart Failure among Patients with Inflammatory Bowel Disease
    Deepak, Parakkal
    Stobaugh, Derrick
    Ehrenpreis, Eli
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S520 - S521
  • [45] Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN
    Gorelik, Yuri
    Freilich, Shay
    Gerassy-Vainberg, Shiran
    Pressman, Sigal
    Friss, Chagit
    Blatt, Alexandera
    Focht, Gili
    Weisband, Yiska Loewenberg
    Greenfeld, Shira
    Kariv, Revital
    Lederman, Nathan
    Dotan, Iris
    Geva-Zatorsky, Naama
    Shen-Orr, Shai Shlomo
    Kashi, Yechezkel
    Chowers, Yehuda
    [J]. GUT, 2022, 71 (02) : 287 - 295
  • [46] New-Onset Inflammatory Bowel Disease During Tumor Necrosis Factor-Alpha Inhibitor Therapy for Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis: A Review of the Food and Drug Administration Adverse Event Reporting System and Literature
    Gong, Lena
    Stobaugh, Derrick
    Deepak, Parakkal
    Ehrenpreis, Eli
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S621 - S622
  • [47] Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)
    Osawa, Takahiro
    Fujii, Yasuhisa
    Kimura, Go
    Kitamura, Hiroshi
    Nagashima, Yoji
    Iizumi, Sakura
    Osaka, Tsuyoshi
    Tsubouchi, Ryoichi
    Shinohara, Nobuo
    [J]. BMJ OPEN, 2023, 13 (07):
12345